Elucidating the specific pharmacological system of action (MOA) of naturally transpiring compounds may be tough. Even though Tarselli et al. (60) developed the primary de novo synthetic pathway to conolidine and showcased that this naturally transpiring compound properly suppresses responses to equally chemically induced and inflammation-derived pa… Read More